Valence exclusively advised a leading pharmaceuticals manufacturer on strategic positioning for their targeted IP sale to global pharmaceutical giants for their life-saving drugs.
Valence Growth Partners was the exclusive advisor to a pharmaceutical manufacturer. Valence advised the pharmaceutical manufacturer on the identification and positioning to global pharmaceutical companies for the strategic targeted sale of their IPs for life saving drugs.
The pharmaceutical manufacturer is a revolutionary company involved in providing novel therapeutics through modern state-of-the-art technology. Over the years, the company has scientifically validated breakthroughs in cholesterol, Parkinsons, Insulin among others.
-
SECTOR
Healthcare
-
REGION
Global
-
ENGAGEMENT TYPE
Advisory
-
DEAL TYPE
Sell-side
Featured Deals
View all deals
Valence advised Memesys Games on fundraising & strategy, securing seed funding from top gaming and media experts and remains a retained strategic advisor.
Valence exclusively advised GoApptiv on their $15M Series A round, on fundraising, strategy and M&A, resulting in a round led by Cipla and HealthQuad.
Valence exclusively advised Co-Develop on their Digital Public Infrastructure thesis and consequently, identifying their LPs and a fiscal sponsor.